Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring

BACKGROUND: Despite a lack of clinical evidence, hydroxychloroquine and azithromycin are being administered widely to patients with verified or suspected coronavirus disease 2019 (COVID‐19). Both drugs may increase risk of lethal arrhythmias associated with QT interval prolongation. METHODS AND RESU...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Am Heart Assoc
Hoofdauteurs: Ramireddy, Archana, Chugh, Harpriya, Reinier, Kyndaron, Ebinger, Joseph, Park, Eunice, Thompson, Michael, Cingolani, Eugenio, Cheng, Susan, Marban, Eduardo, Albert, Christine M., Chugh, Sumeet S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2020
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7429030/
https://ncbi.nlm.nih.gov/pubmed/32463348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.017144
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items